Moderators
Stephen Goldsmith
Derek Bok Professor of the Practice of Urban Policy
Harvard Kennedy School Bloomberg Center
Stephen Goldsmith is the Derek Bok Professor of the Practice of Urban Policy and the Director of the Innovations in American Government Program at Harvard's Kennedy School of Government. He currently directs Data-Smart City Solutions, a project to highlight local government efforts to use new technologies that connect breakthroughs in the use of big data analytics with community input to reshape the relationship between government and citizen. He previously served as Deputy Mayor of New York and Mayor of Indianapolis, where he earned a reputation as one of the country’s leaders in public-private partnerships, competition, and privatization.
David Broecker
Chief Innovation and Collaboration Officer
Purdue Research Foundation
David is an experienced business executive with a passion and track record for building organizations and creating value by advancing breakthrough innovation to the marketplace. He currently serves as the Chief Innovation and Collaboration Officer for Purdue Research Foundation. In this role, David is responsible for advancing strategic innovation initiatives targeting corporate partners and key stakeholders. For the academic 20/21 year, David led the overall Protect Purdue Program to return students and faculty to campus during COVID.
David is the Founder and CEO of Zorion Medical, a leading medical device company focused on developing and commercializing fully absorbable technology utilizing bio- metals. The first set of applications target peripheral artery disease including arterial dissections, congenital vascular defects in children, and AV fistulas in renal- dialysis patients.
Prior to joining Purdue, David was the Founding President and CEO of the Indiana Biosciences Research Institute in Indianapolis, IN – an independent, non-profit research organization dedicated to discovery science and applied research initially targeting diabetes, cardio- metabolic disease, and poor nutrition, inspired by the state’s leading life sciences companies.
David was President and CEO of Alkermes, a publicly traded biotechnology company, leading the organization through significant transformation with the launch of several new products, including Vivitrol - the only long acting treatment for alcohol and opiate dependence. As both an intra- and entrepreneur, he has led teams in a range of organizations, including multiple start-ups. David started his career at Eli Lilly and Company and for more than 15 years was responsible for supporting the development and commercialization of multiple pharmaceutical, medical device, and diagnostic products.
David received his undergraduate degree from Wabash College where he was a chemistry and mathematics major, graduating summa cum laude and as a member of Phi Beta Kappa. He completed a graduate degree in chemical engineering from the Massachusetts Institute of Technology and his M.B.A. from the University of Chicago. He currently serves on the boards of Zorion Medical, Inc., and Apexian Pharmaceuticals and is an advisor and mentor to the next generation of innovators.